
Serotonin-Induced Constriction of Ocular Arteries in Atherosclerotic MonkeysImplications for Ischemic Disorders of the Retina and Optic Nerve Head
Sohan Singh Hayreh, MD, PhD, DSc;
Donald J. Piegors;
Donald D. Heistad, MD
Arch Ophthalmol. 1997;115(2):220-228.
Abstract
 |  |
Background Ischemic disorders of the retina and optic nerve head, which constitute a common cause of visual loss, are usually seen in patients with atherosclerosis.
Objective To test the hypothesis that serotonin, which is released when platelets aggregate, may produce vasospasm in atherosclerotic monkeys and, thus, may contribute to the ischemic disorders and that short-term dietary treatment of atherosclerosis causes the propensity to vasospasm to subside.
Methods We studied the response of retinal and posterior ciliary circulation to serotonin in 18 atherosclerotic (25 eyes) and 5 normal (8 eyes) cynomolgus monkeys. The eyes were evaluated by color fundus photography and fluorescein fundus angiography. The eyes were examined under basal conditions and, at a different time, during the intravenous infusion of serotonin. In 6 of the 18 atherosclerotic animals, the evaluation was repeated 5 to 12 months after discontinuing the atherogenic diet (ie, the regression group).
Results Serotonin had no effect in normal monkeys. In 18 atherosclerotic monkeys, serotonin produced transient occlusion or delayed filling of the central retinal artery and/or posterior ciliary artery (PCA) in 9 eyes of 9 animals, involving the central retinal artery in 5, lateral PCA in 8, and medial PCA in 5, in various combinations. In 6 animals (6 eyes) of the regression group, the vasoconstrictor effect of serotonin was abolished completely, except in the medial PCA in 1 eye.
Conclusions Serotonin, in the presence of atherosclerotic lesions, can cause transient, complete occlusion or impaired blood flow in the central retinal artery and/or PCA. We speculate that this mechanism may play a role in the development of ischemic disorders of the retina and optic nerve head. Discontinuing the atherogenic diet abolished or markedly improved the serotonin-induced vasoconstriction within a few months.
Author Affiliations
From the Departments of Ophthalmology (Dr Hayreh) and Internal Medicine and Pharmacology (Mr Piegors and Dr Heistad), University of Iowa College of Medicine, Iowa City.
CiteULike Connotea Del.icio.us Digg Reddit Technorati Twitter
What's this?
THIS ARTICLE HAS BEEN CITED BY OTHER ARTICLES
Blood pressure and glaucoma
Costa et al.
Br J Ophthalmol 2009;93:1276-1282.
ABSTRACT
| FULL TEXT
Glucose-6-Phosphate Dehydrogenase (G6PD) Deficiency in Nonarteritic Anterior Ischemic Optic Neuropathy in a Sardinian Population, Italy
Pinna et al.
IOVS 2008;49:1328-1332.
ABSTRACT
| FULL TEXT
Blindness in the Intensive Care Unit: Possible Role for Vasopressors?
Lee et al.
Anesth. Analg. 2005;100:192-195.
ABSTRACT
| FULL TEXT
Influence of Experimental Chronic High-Pressure Glaucoma on Age-Related Macular Degeneration in Rhesus Monkeys
Jonas and Hayreh
IOVS 2000;41:2972-2977.
ABSTRACT
| FULL TEXT
Localised retinal nerve fibre layer defects in chronic experimental high pressure glaucoma in rhesus monkeys
Jonas and Hayreh
Br J Ophthalmol 1999;83:1291-1295.
ABSTRACT
| FULL TEXT
|